Stay updated with breaking news from Nasdaq Bmea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) major shareholder A2a Pharmaceuticals, Inc. sold 100,000 shares of Biomea Fusion stock in a transaction on Monday, May 8th. The shares were sold at an average price of $33.99, for a total transaction of $3,399,000.00. Following the completion of the transaction, the insider now owns 3,800,000 shares in […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) traded up 6% during trading on Monday . The company traded as high as $34.96 and last traded at $34.46. 258,080 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 649,297 shares. The stock had previously closed at $32.52. Wall Street […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) shares traded up 5.3% during mid-day trading on Monday . The stock traded as high as $31.32 and last traded at $31.02. 181,852 shares were traded during mid-day trading, a decline of 72% from the average session volume of 654,834 shares. The stock had previously closed at $29.47. […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) shot up 5.3% during trading on Monday . The company traded as high as $31.32 and last traded at $31.02. 181,852 shares changed hands during trading, a decline of 72% from the average session volume of 654,834 shares. The stock had previously closed at $29.47. Wall Street Analyst […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) has been given an average recommendation of “Buy” by the six research firms that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have issued a report on the stock […]